A member asked:

My husband is diagnosed with poorly differentiated adenocarcinoma of the right lung with alk & egfr mutations; stage 3b what is the prognosis and life?

A doctor has provided 1 answer
Dr. Deborah Sculco answered

Specializes in Hematology and Oncology

It is extremely unusual to have both mutations. They are mutually exclusive. Patients that do carry one of these mutations are eligible for various medications that target these mutations. Crizonitib for alk and tarceva (erlotinib) for egfr and new agent recently to the market. These new finding have improved the prognosis. Other factors do enter in. Age, ps, smoking history if any, wt. Loss, etc.

Answered Feb 8, 2014



Still have questions?

Get the best care from a doctor who knows you.

Book a Video Appointment
Sponsor Content

Related Questions

Online Primary Care Doctors Accepting New Patients

$44 video appointments available today with a membership as low as $15/month

Book a Video Appointment
Ask your question
Didn't find what you're looking for?

90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.

Ask your question

Meet your new favorite doctor